Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
7
pubmed:dateCreated
1999-10-21
pubmed:abstractText
The intention of this study was to mimic a naturally occurring stimulation by allergens and bacterial infection in order to determine whether specific allergen-induced, inflammatory responses may be changed or modified by bacterial products. Blood leukocytes from six atopic and six nonatopic individuals were examined for their surface expression of CD154, CD11a, and HLA-DR molecules and for secretion of IgE, eosinophil cationic protein (ECP), and the cytokines interleukin (IL)-4 and IL-5. Signals through CD154 are required for activation and proliferation of effector cells associated with the allergic, inflammatory response. HLA-DR and CD11a/CD18-mediated interactions are also involved in T- and B-cell functions. Birch-pollen (BP) allergens induced CD154 expression on CD3-positive lymphocytes only in atopic individuals. In nonatopics, the expression of CD154 could be induced only after exposure to BP and subsequent lipopolysaccharide (LPS) stimulation. Levels of CD154 expression were always higher in atopics than nonatopics. CD11a and HLA-DR expressions were upregulated, irrespective of atopic state, after BP and/or LPS stimulation. The increased secretion of IL-5 and total IgE in BP-supplemented cell cultures indicated that an allergic response had occurred. In conclusion, the results of this report do not support the hypothesis of a changed inflammatory response stimulated by the combined action of bacteria and allergens, as compared to allergen provocation alone.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
0105-4538
pubmed:author
pubmed:issnType
Print
pubmed:volume
54
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
722-9
pubmed:dateRevised
2004-11-17
pubmed:meshHeading
pubmed-meshheading:10442528-Adult, pubmed-meshheading:10442528-Allergens, pubmed-meshheading:10442528-Antigens, CD3, pubmed-meshheading:10442528-CD40 Ligand, pubmed-meshheading:10442528-Female, pubmed-meshheading:10442528-HLA-DR Antigens, pubmed-meshheading:10442528-Humans, pubmed-meshheading:10442528-Hypersensitivity, Immediate, pubmed-meshheading:10442528-Interleukin-4, pubmed-meshheading:10442528-Interleukin-5, pubmed-meshheading:10442528-Leukocytes, Mononuclear, pubmed-meshheading:10442528-Lipopolysaccharides, pubmed-meshheading:10442528-Lymphocyte Function-Associated Antigen-1, pubmed-meshheading:10442528-Male, pubmed-meshheading:10442528-Membrane Glycoproteins, pubmed-meshheading:10442528-Middle Aged, pubmed-meshheading:10442528-Pollen, pubmed-meshheading:10442528-T-Lymphocyte Subsets, pubmed-meshheading:10442528-Trees
pubmed:year
1999
pubmed:articleTitle
Allergen-stimulated expression of CD154 (CD40 ligand) on CD3+ lymphocytes in atopic, but not in nonatopic individuals. Modulation by bacterial lipopolysaccharide.
pubmed:affiliation
Research Forum, Ullevål University Hospital, Oslo, Norway.
pubmed:publicationType
Journal Article